SWATH-MS Based Proteomic Profiling of Prostate Cancer Cells Reveals Adaptive Molecular Mechanisms in Response to Anti-Androgen Therapy.

Liyanage, Chamikara; Malik, Adil; Abeysinghe, Pevindu; Clements, Judith; Batra, Jyotsna

Liyanage, Chamikara; Malik, Adil; Abeysinghe, Pevindu; Clements, Judith; Batra, Jyotsna.

Afiliación

Liyanage C; Faculty of Health, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Malik A; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Translational Research Institute, Queensland University of Technology, Brisbane, QLD 4012, Australia.
Abeysinghe P; Faculty of Health, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Clements J; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Translational Research Institute, Queensland University of Technology, Brisbane, QLD 4012, Australia.
Batra J; Faculty of Health, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.

Cancers (Basel) ; 13(4)2021 Feb 09.

Article en En | MEDLINE | ID: mdl-33572476

Palabras clave

anti-androgen therapy; bicalutamide; enzalutamide; prostate cancer; proteomics; transcriptomics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google